Abstract:It is impossible to ignore the rapidly growing interest in the therapeutic use of psychedelics. Once marginalized as elements of counterculture, substances such as lysergic acid diethylamide (LSD) have catapulted into the limelight. Traditionally, psychedelic therapy has involved administering "macro" doses, leading to potent psychoactive effects (the psychedelic "trip"). Although these effects are assumed to have therapeutic merits some argue that they may limit the broader application of these emerging interventions [1]. "Microdosing", an alternative approach that involves taking sub-hallucinogenic doses of psychedelics for mental health benefit, is being evaluated in clinical populations. At the same time, mechanisms of effects of psychedelics (both macro and microdosed) are being evaluated. In this context, the recent report by Murray et al. published in Neuropsychopharmacology is a relevant contribution to the field [2]. Pooling data from three previous studies, the authors evaluated the relationship between electroencephalography (EEG) measures of neural complexity across drug classes and doses in healthy participants. Neural complexity refers to the diversity and richness of brain activity patterns. It is hypothesized that serotonin 2A receptor (5-HT 2A ) receptor agonism induces changes in neural complexity during the subjective psychedelic experience, serving as a key mechanism for therapeutic effects [2]. Murray et al. conducted a secondary analysis involving 73 healthy adults that compared microdoses of either LSD (13 and 26 μg), tetrahydrocannabinol (THC) (7.5 and 15 mg), or methamphetamine (10 and 20 mg) against placebo. Each participant underwent three sessions during which they received either a placebo or one of two doses of the respective drugs. They assessed clinical measures including the 5 Dimensions of Altered State of Consciousness (5D-ASC), a self-reported measure of the subjective psychedelic experience, and EEG measures of neural complexity (Limpel-Ziv Complexity).

Effects of psychedelics on neurogenesis and brain plasticity: A systematic review

Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models

The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis

A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder

Robust Methods For Quantifying Neuronal Morphology And Molecular Signaling Reveal That Psychedelics Do Not Induce Neuroplasticity

Psychedelics and Neural Plasticity: Therapeutic Implications

Psychedelics and Other Psychoplastogens for Treating Mental Illness

Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology

[Therapeutic applications of classical serotonergic psyche-delics: neurobiological mechanisms and neural networks]

Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review

Molecular and Medical Aspects of Psychedelics

Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential

Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain

Classical psychedelics' action on brain monoaminergic systems

Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology

Neurogenesis and Its Links to Brain Development, Developmental Therapeutics, and the Pathogenesis of Neurodegenerative Disorders Including HIV-1-associated Dementia

New Paradigms of Old Psychedelics in Schizophrenia

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

Emerging Pro-neurogenic Therapeutic Strategies for Neurodegenerative Diseases: A Review of Pre-clinical and Clinical Research

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology

Neural effects of psychedelics: Complexity the key word